Velneperit
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
Shionogi · Phase 2 · Completed · Enrollment 724
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| S-2367 Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| S-2367 800 mg | Obesity or overweight | 800 mg | n/r | n/r | n/r |
| S-2367 1600 mg | Obesity or overweight | 1600 mg | n/r | n/r | n/r |